Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study

Affiliations

• ¹ Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands. j.m.boer-20@prinsesmaximacentrum.nl.
• ² Oncode Institute, Utrecht, Netherlands. j.m.boer-20@prinsesmaximacentrum.nl.
• ³ Interfant Trial Data Center, School of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy.
• ⁴ Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
• ⁵ Oncode Institute, Utrecht, Netherlands.
• ⁶ Institute of Human Genetics, Medical School Hannover, Hannover, Germany.
• ⁷ CLIP, Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
• ⁸ Leukaemia Research Cytogenetics Group, Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
• ⁹ Tettamanti Research Center, Pediatric Clinic, University of Milan-Bicocca, Monza, Italy.
• ¹⁰ Department of Genetics, Robert Debré Hospital and University of Paris, Paris, France.
• ¹¹ Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.
• ¹² CCRI, St. Anna Children's Cancer Research Institute, Vienna, Austria.
• ¹³ Department of Pediatric Hematology and Oncology, University Medical Center Hamburg, Hamburg, Germany.
• ¹⁴ Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan.
• ¹⁵ Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan.
• ¹⁶ Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
• ¹⁷ Children's Cancer Institute Australia, Lowy Cancer Research Centre, University of NSW, Randwick, NSW, Australia.
• ¹⁸ Department of Pediatric Oncology and Hematology, Medical University of Lodz, Lodz, CA, Poland.
• ¹⁹ Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
• ²⁰ Department of Pediatric Hemato-oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.
• ²¹ Centre Hospitalier Universitaire de Liège, Liege, Belgium.
• ²² Department of Paediatrics, The Chinese University of Hong Kong, Shatin, Hong Kong.
• ²³ Computational Biology Group, Precision Nutrition and Cancer Research Program, IMDEA Food Institute, Madrid, Spain.
• ²⁴ Computational Biology, Leibniz Institute on Ageing-Fritz Lipmann Institute (FLI), Jena, Germany.
• ²⁵ Department of Pediatrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
• ²⁶ Erasmus MC-Sophia Children's Hospital, Department of Pediatric Oncology/Hematology, Rotterdam, Netherlands.